A Study to Evaluate the Effect of BioK+ 50B® on Glycemic Control in a Type 2 Diabetes Population
Phase 2
- Conditions
- Type2 Diabetes
- Interventions
- Other: BioK+ 100% probioticOther: Placebo
- First Posted Date
- 2017-08-04
- Last Posted Date
- 2019-01-22
- Lead Sponsor
- Bio-K Plus International Inc.
- Target Recruit Count
- 130
- Registration Number
- NCT03239366
- Locations
- 🇨🇦
Montreal Heart Institute, Montréal, Quebec, Canada
Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea
Phase 4
Terminated
- Conditions
- Clostridium Difficile InfectionAntibiotic Associated Diarrhea
- Interventions
- Dietary Supplement: Bio K+® 2 capsules orally (or via nasogastric tube)Dietary Supplement: Placebo
- First Posted Date
- 2013-10-31
- Last Posted Date
- 2022-07-22
- Lead Sponsor
- Bio-K Plus International Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT01972932
- Locations
- 🇨🇦
Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada
Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome
Phase 2
Completed
- Conditions
- Irritable Bowel Syndrome
- Interventions
- Other: PlaceboDietary Supplement: L. acidophilus CL1285® + L. casei LBC80R® + L. rhamnosus CLR2®
- First Posted Date
- 2012-03-06
- Last Posted Date
- 2017-07-31
- Lead Sponsor
- Bio-K Plus International Inc.
- Target Recruit Count
- 117
- Registration Number
- NCT01545037
- Locations
- 🇺🇸
Digestive and Liver Disease Specialists A Medical Group. Inc, Garden Grove, California, United States
🇺🇸Sprim ALS, San Francisco, California, United States
🇺🇸Westlake Medical Research, Westlake Village, California, United States
BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile Infection
Phase 3
Suspended
- Conditions
- Recurrent Clostridium Difficile Infection
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Lactobacillus acidophilus CL1285® and Lactobacillus casei
- First Posted Date
- 2010-09-16
- Last Posted Date
- 2016-01-15
- Lead Sponsor
- Bio-K Plus International Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT01202630
- Locations
- 🇺🇸
Parker Jewish Institute, New Hyde Park, New York, United States
Efficacy and Safety Study in the Prevention of Antibiotic-Associated Diarrhea (AAD) and Clostridium Difficile-Associated Diarrhea (CDAD) in Hospitalized Adult Patients Exposed to Nosocomial Infection
Phase 3
Completed
- Conditions
- Antibiotic-Associated DiarrheaClostridium Difficile-Associated Diarrhea
- Interventions
- Other: PlaceboOther: BIO-K+ CL-1285®
- First Posted Date
- 2009-08-13
- Last Posted Date
- 2012-03-13
- Lead Sponsor
- Bio-K Plus International Inc.
- Target Recruit Count
- 255
- Registration Number
- NCT00958308
Evaluation of the Efficacy of Bio-K+ Cl-1285® In the Nasal Decolonization of Methicillin Resistant Staphylococcus Aureus (MRSA) Carrier Patients
Phase 2
Withdrawn
- Conditions
- MRSA Colonization
- Interventions
- Dietary Supplement: Bio-K+ CL1285Dietary Supplement: Placebo
- First Posted Date
- 2009-07-17
- Last Posted Date
- 2022-07-22
- Lead Sponsor
- Bio-K Plus International Inc.
- Registration Number
- NCT00941356
- Locations
- 🇨🇦
Pierre Le Gardeur Hospital, Terrebonne, Quebec, Canada
Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults
Phase 3
Completed
- Conditions
- Diarrhea
- Interventions
- Other: Placebo
- First Posted Date
- 2008-08-19
- Last Posted Date
- 2010-01-21
- Lead Sponsor
- Bio-K Plus International Inc.
- Target Recruit Count
- 277
- Registration Number
- NCT00737412
- Locations
- 🇨🇦
Clinique Santé Voyage des Prairies, Joliette, Quebec, Canada
🇨🇦Clinique Santé Voyage de Laval, Laval, Quebec, Canada
🇨🇦Sant Voyage Medisys, Montreal, Quebec, Canada
Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adult Patients
Phase 3
Completed
- Conditions
- DiarrheaClostridium Infections
- Interventions
- Dietary Supplement: Lactobacillus acidophilus CL1285 and Lactobacillus caseiDietary Supplement: placebo
- First Posted Date
- 2006-05-19
- Last Posted Date
- 2014-08-07
- Lead Sponsor
- Bio-K Plus International Inc.
- Target Recruit Count
- 472
- Registration Number
- NCT00328263
- Locations
- 🇨🇦
St-Mary Hospital Center, Montreal, Quebec, Canada
🇨🇦Hotel Dieu de Chicoutimi, Chicoutimi, Quebec, Canada
🇨🇦Hotel-Dieu de St-Jerome, St-Jerome, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath